Similar Papers

Paper Title
Journal
Date
Author
P202 Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum
F Bantleon ... F Magro
Journal of Crohn's and Colitis | VOL. 13
F Bantleon, et. al.F Bantleon ... F Magro
25 Jan 2019
P2.21 Feasibility study for the development of a rapid lateral flow point of care test for congenital syphilis
John Deutsch ... Yetunda F Fakile
Sexually Transmitted Infections | VOL. 93
John Deutsch, et. al.John Deutsch ... Yetunda F Fakile
01 Jul 2017
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce
D.M Favara ... N.L Ainsworth
Clinical Oncology | VOL. 33
D.M Favara, et. al.D.M Favara ... N.L Ainsworth
25 Jul 2020
Sedimentation velocity FDS studies of antibodies in pooled human serum.
J J Correia ... W F Stafford
European Biophysics Journal | VOL. 52
J J Correia, et. al.J J Correia ... W F Stafford
09 May 2023
View more papers

More From: Journal of Crohn's and Colitis

Paper Title
Journal
Date
Author
P0222 Predicting corticosteroid failure in Acute Severe Ulcerative Colitis at admission using the ADMIT-ASC score
P Chan ... L Thin
Journal of Crohn's and Colitis | VOL. 19
P Chan, et. al.P Chan ... L Thin
22 Jan 2025
DOP114 LDN-071, the novel amino acid-based PAI-1 inhibitor, significantly reduces the severity of acute and chronic inflammation in colitis models
B Jójárt ...
Journal of Crohn's and Colitis | VOL. 19
B Jójárt, et. al.B Jójárt ...
22 Jan 2025
P0416 Efficacy and safety of oral sulphate tablet for bowel preparation in patients with moderate to severe ulcerative colitis: a multicenter cohort study
J H Song ... K S Kwon
Journal of Crohn's and Colitis | VOL. 19
J H Song, et. al.J H Song ... K S Kwon
22 Jan 2025
P0595 Comparative effectiveness between ustekinumab and vedolizumab after anti-TNF failure in Ulcerative Colitis: Real-world experience
R Jairath ... T Bessissow
Journal of Crohn's and Colitis | VOL. 19
R Jairath, et. al.R Jairath ... T Bessissow
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.